nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprepitant—CYP3A7—Ifosfamide—germ cell cancer	0.113	0.188	CbGbCtD
Aprepitant—CYP3A7-CYP3A51P—Ifosfamide—germ cell cancer	0.113	0.188	CbGbCtD
Aprepitant—CYP3A5—Ifosfamide—germ cell cancer	0.0847	0.141	CbGbCtD
Aprepitant—TACR3—iris—germ cell cancer	0.0705	0.43	CbGeAlD
Aprepitant—CYP2C19—Ifosfamide—germ cell cancer	0.0683	0.114	CbGbCtD
Aprepitant—CYP2C9—Ifosfamide—germ cell cancer	0.0568	0.0946	CbGbCtD
Aprepitant—CYP3A5—Etoposide—germ cell cancer	0.0405	0.0674	CbGbCtD
Aprepitant—CYP3A4—Ifosfamide—germ cell cancer	0.033	0.055	CbGbCtD
Aprepitant—CYP1A2—Etoposide—germ cell cancer	0.0301	0.0502	CbGbCtD
Aprepitant—CYP2C9—Cisplatin—germ cell cancer	0.0276	0.046	CbGbCtD
Aprepitant—CYP3A4—Vinblastine—germ cell cancer	0.0175	0.0292	CbGbCtD
Aprepitant—CYP3A4—Etoposide—germ cell cancer	0.0158	0.0263	CbGbCtD
Aprepitant—TACR1—trigeminal nerve—germ cell cancer	0.0136	0.0833	CbGeAlD
Aprepitant—TACR1—vagus nerve—germ cell cancer	0.0128	0.0779	CbGeAlD
Aprepitant—CYP2C9—cardial valve—germ cell cancer	0.00991	0.0605	CbGeAlD
Aprepitant—TACR1—cranial nerve—germ cell cancer	0.00972	0.0594	CbGeAlD
Aprepitant—TACR3—brainstem—germ cell cancer	0.00552	0.0337	CbGeAlD
Aprepitant—TACR1—ganglion—germ cell cancer	0.00492	0.03	CbGeAlD
Aprepitant—TACR3—telencephalon—germ cell cancer	0.0049	0.0299	CbGeAlD
Aprepitant—TACR3—head—germ cell cancer	0.00305	0.0186	CbGeAlD
Aprepitant—CYP2C19—urine—germ cell cancer	0.00276	0.0168	CbGeAlD
Aprepitant—TACR3—cerebellum—germ cell cancer	0.00272	0.0166	CbGeAlD
Aprepitant—CYP1A2—urine—germ cell cancer	0.00225	0.0138	CbGeAlD
Aprepitant—TACR3—brain—germ cell cancer	0.00221	0.0135	CbGeAlD
Aprepitant—TACR1—brainstem—germ cell cancer	0.00214	0.0131	CbGeAlD
Aprepitant—CYP2C9—urine—germ cell cancer	0.00214	0.0131	CbGeAlD
Aprepitant—TACR1—telencephalon—germ cell cancer	0.0019	0.0116	CbGeAlD
Aprepitant—CYP3A4—urine—germ cell cancer	0.00163	0.00995	CbGeAlD
Aprepitant—TACR1—adrenal gland—germ cell cancer	0.00138	0.00843	CbGeAlD
Aprepitant—TACR1—spinal cord—germ cell cancer	0.00133	0.00812	CbGeAlD
Aprepitant—TACR1—endocrine gland—germ cell cancer	0.0012	0.00731	CbGeAlD
Aprepitant—TACR1—head—germ cell cancer	0.00118	0.00722	CbGeAlD
Aprepitant—TACR1—testis—germ cell cancer	0.00114	0.00697	CbGeAlD
Aprepitant—CYP3A7—endocrine gland—germ cell cancer	0.00102	0.00625	CbGeAlD
Aprepitant—TACR1—brain—germ cell cancer	0.000857	0.00523	CbGeAlD
Aprepitant—TACR1—lymph node—germ cell cancer	0.000828	0.00505	CbGeAlD
Aprepitant—CYP2C19—endocrine gland—germ cell cancer	0.000457	0.00279	CbGeAlD
Aprepitant—CYP3A5—female gonad—germ cell cancer	0.000387	0.00236	CbGeAlD
Aprepitant—CYP1A2—endocrine gland—germ cell cancer	0.000373	0.00228	CbGeAlD
Aprepitant—CYP3A5—endocrine gland—germ cell cancer	0.00036	0.0022	CbGeAlD
Aprepitant—Alopecia—Cisplatin—germ cell cancer	0.000356	0.00151	CcSEcCtD
Aprepitant—Cough—Ifosfamide—germ cell cancer	0.000355	0.0015	CcSEcCtD
Aprepitant—CYP2C9—endocrine gland—germ cell cancer	0.000355	0.00216	CbGeAlD
Aprepitant—Thrombocytopenia—Dactinomycin—germ cell cancer	0.000354	0.0015	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.000353	0.0015	CcSEcCtD
Aprepitant—Convulsion—Ifosfamide—germ cell cancer	0.000352	0.00149	CcSEcCtD
Aprepitant—Hypertension—Ifosfamide—germ cell cancer	0.000351	0.00149	CcSEcCtD
Aprepitant—Malnutrition—Cisplatin—germ cell cancer	0.00035	0.00148	CcSEcCtD
Aprepitant—Erythema—Cisplatin—germ cell cancer	0.00035	0.00148	CcSEcCtD
Aprepitant—Erythema multiforme—Etoposide—germ cell cancer	0.000349	0.00148	CcSEcCtD
Aprepitant—Paraesthesia—Bleomycin—germ cell cancer	0.000348	0.00148	CcSEcCtD
Aprepitant—Dyspnoea—Bleomycin—germ cell cancer	0.000346	0.00147	CcSEcCtD
Aprepitant—Arthralgia—Ifosfamide—germ cell cancer	0.000346	0.00147	CcSEcCtD
Aprepitant—Chest pain—Ifosfamide—germ cell cancer	0.000346	0.00147	CcSEcCtD
Aprepitant—Myalgia—Ifosfamide—germ cell cancer	0.000346	0.00147	CcSEcCtD
Aprepitant—Flatulence—Cisplatin—germ cell cancer	0.000345	0.00146	CcSEcCtD
Aprepitant—Anorexia—Dactinomycin—germ cell cancer	0.000345	0.00146	CcSEcCtD
Aprepitant—Eye disorder—Etoposide—germ cell cancer	0.000344	0.00146	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.000344	0.00146	CcSEcCtD
Aprepitant—Cardiac disorder—Etoposide—germ cell cancer	0.000342	0.00145	CcSEcCtD
Aprepitant—Flushing—Etoposide—germ cell cancer	0.000342	0.00145	CcSEcCtD
Aprepitant—Discomfort—Ifosfamide—germ cell cancer	0.000342	0.00145	CcSEcCtD
Aprepitant—Hypersensitivity—Vinblastine—germ cell cancer	0.000338	0.00143	CcSEcCtD
Aprepitant—Decreased appetite—Bleomycin—germ cell cancer	0.000337	0.00143	CcSEcCtD
Aprepitant—Muscle spasms—Cisplatin—germ cell cancer	0.000337	0.00143	CcSEcCtD
Aprepitant—Angiopathy—Etoposide—germ cell cancer	0.000334	0.00142	CcSEcCtD
Aprepitant—Confusional state—Ifosfamide—germ cell cancer	0.000334	0.00142	CcSEcCtD
Aprepitant—Immune system disorder—Etoposide—germ cell cancer	0.000333	0.00141	CcSEcCtD
Aprepitant—Mediastinal disorder—Etoposide—germ cell cancer	0.000332	0.00141	CcSEcCtD
Aprepitant—Pain—Bleomycin—germ cell cancer	0.000332	0.00141	CcSEcCtD
Aprepitant—Anaphylactic shock—Ifosfamide—germ cell cancer	0.000332	0.00141	CcSEcCtD
Aprepitant—Oedema—Ifosfamide—germ cell cancer	0.000332	0.00141	CcSEcCtD
Aprepitant—Chills—Etoposide—germ cell cancer	0.000331	0.0014	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00033	0.0014	CcSEcCtD
Aprepitant—Asthenia—Vinblastine—germ cell cancer	0.00033	0.0014	CcSEcCtD
Aprepitant—Infection—Ifosfamide—germ cell cancer	0.000329	0.0014	CcSEcCtD
Aprepitant—Tremor—Cisplatin—germ cell cancer	0.000328	0.00139	CcSEcCtD
Aprepitant—Alopecia—Etoposide—germ cell cancer	0.000326	0.00138	CcSEcCtD
Aprepitant—Lethargy—Methotrexate—germ cell cancer	0.000326	0.00138	CcSEcCtD
Aprepitant—Nervous system disorder—Ifosfamide—germ cell cancer	0.000325	0.00138	CcSEcCtD
Aprepitant—Ill-defined disorder—Cisplatin—germ cell cancer	0.000325	0.00138	CcSEcCtD
Aprepitant—Thrombocytopenia—Ifosfamide—germ cell cancer	0.000325	0.00138	CcSEcCtD
Aprepitant—Anaemia—Cisplatin—germ cell cancer	0.000324	0.00137	CcSEcCtD
Aprepitant—Skin disorder—Ifosfamide—germ cell cancer	0.000322	0.00136	CcSEcCtD
Aprepitant—Hyperhidrosis—Ifosfamide—germ cell cancer	0.000321	0.00136	CcSEcCtD
Aprepitant—Feeling abnormal—Bleomycin—germ cell cancer	0.00032	0.00135	CcSEcCtD
Aprepitant—Osteoarthritis—Methotrexate—germ cell cancer	0.000319	0.00135	CcSEcCtD
Aprepitant—Anorexia—Ifosfamide—germ cell cancer	0.000316	0.00134	CcSEcCtD
Aprepitant—Malaise—Cisplatin—germ cell cancer	0.000316	0.00134	CcSEcCtD
Aprepitant—Decreased appetite—Dactinomycin—germ cell cancer	0.000315	0.00133	CcSEcCtD
Aprepitant—Diarrhoea—Vinblastine—germ cell cancer	0.000314	0.00133	CcSEcCtD
Aprepitant—Dysgeusia—Etoposide—germ cell cancer	0.000314	0.00133	CcSEcCtD
Aprepitant—Fatigue—Dactinomycin—germ cell cancer	0.000312	0.00132	CcSEcCtD
Aprepitant—Back pain—Etoposide—germ cell cancer	0.00031	0.00132	CcSEcCtD
Aprepitant—Hypotension—Ifosfamide—germ cell cancer	0.00031	0.00131	CcSEcCtD
Aprepitant—Pain—Dactinomycin—germ cell cancer	0.000309	0.00131	CcSEcCtD
Aprepitant—Muscle spasms—Etoposide—germ cell cancer	0.000309	0.00131	CcSEcCtD
Aprepitant—Urticaria—Bleomycin—germ cell cancer	0.000308	0.00131	CcSEcCtD
Aprepitant—Body temperature increased—Bleomycin—germ cell cancer	0.000307	0.0013	CcSEcCtD
Aprepitant—Dizziness—Vinblastine—germ cell cancer	0.000304	0.00129	CcSEcCtD
Aprepitant—Convulsion—Cisplatin—germ cell cancer	0.000303	0.00129	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.000302	0.00128	CcSEcCtD
Aprepitant—Myalgia—Cisplatin—germ cell cancer	0.000298	0.00126	CcSEcCtD
Aprepitant—Feeling abnormal—Dactinomycin—germ cell cancer	0.000298	0.00126	CcSEcCtD
Aprepitant—Paraesthesia—Ifosfamide—germ cell cancer	0.000298	0.00126	CcSEcCtD
Aprepitant—Ill-defined disorder—Etoposide—germ cell cancer	0.000298	0.00126	CcSEcCtD
Aprepitant—Anxiety—Cisplatin—germ cell cancer	0.000297	0.00126	CcSEcCtD
Aprepitant—Anaemia—Etoposide—germ cell cancer	0.000297	0.00126	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.000296	0.00125	CcSEcCtD
Aprepitant—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.000296	0.00125	CcSEcCtD
Aprepitant—Dyspnoea—Ifosfamide—germ cell cancer	0.000296	0.00125	CcSEcCtD
Aprepitant—Somnolence—Ifosfamide—germ cell cancer	0.000295	0.00125	CcSEcCtD
Aprepitant—Discomfort—Cisplatin—germ cell cancer	0.000295	0.00125	CcSEcCtD
Aprepitant—Vomiting—Vinblastine—germ cell cancer	0.000292	0.00124	CcSEcCtD
Aprepitant—Malaise—Etoposide—germ cell cancer	0.000289	0.00123	CcSEcCtD
Aprepitant—Breast disorder—Methotrexate—germ cell cancer	0.000288	0.00122	CcSEcCtD
Aprepitant—Decreased appetite—Ifosfamide—germ cell cancer	0.000288	0.00122	CcSEcCtD
Aprepitant—Headache—Vinblastine—germ cell cancer	0.000288	0.00122	CcSEcCtD
Aprepitant—Toxic epidermal necrolysis—Methotrexate—germ cell cancer	0.000287	0.00122	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.000286	0.00121	CcSEcCtD
Aprepitant—Abdominal pain—Dactinomycin—germ cell cancer	0.000286	0.00121	CcSEcCtD
Aprepitant—Body temperature increased—Dactinomycin—germ cell cancer	0.000286	0.00121	CcSEcCtD
Aprepitant—Fatigue—Ifosfamide—germ cell cancer	0.000286	0.00121	CcSEcCtD
Aprepitant—Anaphylactic shock—Cisplatin—germ cell cancer	0.000286	0.00121	CcSEcCtD
Aprepitant—Oedema—Cisplatin—germ cell cancer	0.000286	0.00121	CcSEcCtD
Aprepitant—Hypersensitivity—Bleomycin—germ cell cancer	0.000286	0.00121	CcSEcCtD
Aprepitant—Infection—Cisplatin—germ cell cancer	0.000284	0.0012	CcSEcCtD
Aprepitant—Constipation—Ifosfamide—germ cell cancer	0.000284	0.0012	CcSEcCtD
Aprepitant—Pain—Ifosfamide—germ cell cancer	0.000284	0.0012	CcSEcCtD
Aprepitant—Loss of consciousness—Etoposide—germ cell cancer	0.000282	0.0012	CcSEcCtD
Aprepitant—Nervous system disorder—Cisplatin—germ cell cancer	0.00028	0.00119	CcSEcCtD
Aprepitant—Cough—Etoposide—germ cell cancer	0.00028	0.00119	CcSEcCtD
Aprepitant—Thrombocytopenia—Cisplatin—germ cell cancer	0.00028	0.00119	CcSEcCtD
Aprepitant—Tachycardia—Cisplatin—germ cell cancer	0.000279	0.00118	CcSEcCtD
Aprepitant—Asthenia—Bleomycin—germ cell cancer	0.000278	0.00118	CcSEcCtD
Aprepitant—Convulsion—Etoposide—germ cell cancer	0.000278	0.00118	CcSEcCtD
Aprepitant—Skin disorder—Cisplatin—germ cell cancer	0.000278	0.00118	CcSEcCtD
Aprepitant—Hypertension—Etoposide—germ cell cancer	0.000277	0.00117	CcSEcCtD
Aprepitant—Hyperhidrosis—Cisplatin—germ cell cancer	0.000276	0.00117	CcSEcCtD
Aprepitant—Pruritus—Bleomycin—germ cell cancer	0.000274	0.00116	CcSEcCtD
Aprepitant—Feeling abnormal—Ifosfamide—germ cell cancer	0.000273	0.00116	CcSEcCtD
Aprepitant—Chest pain—Etoposide—germ cell cancer	0.000273	0.00116	CcSEcCtD
Aprepitant—Nausea—Vinblastine—germ cell cancer	0.000273	0.00116	CcSEcCtD
Aprepitant—Anorexia—Cisplatin—germ cell cancer	0.000272	0.00115	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.000271	0.00115	CcSEcCtD
Aprepitant—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.000271	0.00115	CcSEcCtD
Aprepitant—CYP3A4—endocrine gland—germ cell cancer	0.00027	0.00165	CbGeAlD
Aprepitant—Discomfort—Etoposide—germ cell cancer	0.00027	0.00114	CcSEcCtD
Aprepitant—Hypotension—Cisplatin—germ cell cancer	0.000267	0.00113	CcSEcCtD
Aprepitant—Hypersensitivity—Dactinomycin—germ cell cancer	0.000267	0.00113	CcSEcCtD
Aprepitant—Abdominal discomfort—Methotrexate—germ cell cancer	0.000264	0.00112	CcSEcCtD
Aprepitant—Confusional state—Etoposide—germ cell cancer	0.000264	0.00112	CcSEcCtD
Aprepitant—Urticaria—Ifosfamide—germ cell cancer	0.000263	0.00112	CcSEcCtD
Aprepitant—Abdominal pain—Ifosfamide—germ cell cancer	0.000262	0.00111	CcSEcCtD
Aprepitant—Body temperature increased—Ifosfamide—germ cell cancer	0.000262	0.00111	CcSEcCtD
Aprepitant—Anaphylactic shock—Etoposide—germ cell cancer	0.000262	0.00111	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00026	0.0011	CcSEcCtD
Aprepitant—Infection—Etoposide—germ cell cancer	0.00026	0.0011	CcSEcCtD
Aprepitant—Asthenia—Dactinomycin—germ cell cancer	0.00026	0.0011	CcSEcCtD
Aprepitant—Neutropenia—Methotrexate—germ cell cancer	0.000258	0.00109	CcSEcCtD
Aprepitant—Dysuria—Methotrexate—germ cell cancer	0.000258	0.00109	CcSEcCtD
Aprepitant—Paraesthesia—Cisplatin—germ cell cancer	0.000257	0.00109	CcSEcCtD
Aprepitant—Thrombocytopenia—Etoposide—germ cell cancer	0.000256	0.00109	CcSEcCtD
Aprepitant—Upper respiratory tract infection—Methotrexate—germ cell cancer	0.000256	0.00109	CcSEcCtD
Aprepitant—Tachycardia—Etoposide—germ cell cancer	0.000256	0.00108	CcSEcCtD
Aprepitant—Dyspnoea—Cisplatin—germ cell cancer	0.000255	0.00108	CcSEcCtD
Aprepitant—Skin disorder—Etoposide—germ cell cancer	0.000254	0.00108	CcSEcCtD
Aprepitant—Hyperhidrosis—Etoposide—germ cell cancer	0.000253	0.00107	CcSEcCtD
Aprepitant—Photosensitivity reaction—Methotrexate—germ cell cancer	0.000252	0.00107	CcSEcCtD
Aprepitant—Anorexia—Etoposide—germ cell cancer	0.00025	0.00106	CcSEcCtD
Aprepitant—Decreased appetite—Cisplatin—germ cell cancer	0.000249	0.00105	CcSEcCtD
Aprepitant—Diarrhoea—Dactinomycin—germ cell cancer	0.000248	0.00105	CcSEcCtD
Aprepitant—Pneumonia—Methotrexate—germ cell cancer	0.000247	0.00105	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.000247	0.00105	CcSEcCtD
Aprepitant—Vomiting—Bleomycin—germ cell cancer	0.000247	0.00105	CcSEcCtD
Aprepitant—Infestation NOS—Methotrexate—germ cell cancer	0.000246	0.00104	CcSEcCtD
Aprepitant—Infestation—Methotrexate—germ cell cancer	0.000246	0.00104	CcSEcCtD
Aprepitant—Hypotension—Etoposide—germ cell cancer	0.000245	0.00104	CcSEcCtD
Aprepitant—Rash—Bleomycin—germ cell cancer	0.000245	0.00104	CcSEcCtD
Aprepitant—Pain—Cisplatin—germ cell cancer	0.000244	0.00104	CcSEcCtD
Aprepitant—Dermatitis—Bleomycin—germ cell cancer	0.000244	0.00104	CcSEcCtD
Aprepitant—Hypersensitivity—Ifosfamide—germ cell cancer	0.000244	0.00104	CcSEcCtD
Aprepitant—Stevens-Johnson syndrome—Methotrexate—germ cell cancer	0.000244	0.00103	CcSEcCtD
Aprepitant—Renal failure—Methotrexate—germ cell cancer	0.000242	0.00102	CcSEcCtD
Aprepitant—Stomatitis—Methotrexate—germ cell cancer	0.00024	0.00102	CcSEcCtD
Aprepitant—Conjunctivitis—Methotrexate—germ cell cancer	0.000239	0.00101	CcSEcCtD
Aprepitant—Asthenia—Ifosfamide—germ cell cancer	0.000238	0.00101	CcSEcCtD
Aprepitant—Feeling abnormal—Cisplatin—germ cell cancer	0.000236	0.000998	CcSEcCtD
Aprepitant—Paraesthesia—Etoposide—germ cell cancer	0.000235	0.000996	CcSEcCtD
Aprepitant—Pruritus—Ifosfamide—germ cell cancer	0.000235	0.000994	CcSEcCtD
Aprepitant—Haematuria—Methotrexate—germ cell cancer	0.000235	0.000994	CcSEcCtD
Aprepitant—Dyspnoea—Etoposide—germ cell cancer	0.000233	0.000989	CcSEcCtD
Aprepitant—Somnolence—Etoposide—germ cell cancer	0.000233	0.000987	CcSEcCtD
Aprepitant—Nausea—Bleomycin—germ cell cancer	0.00023	0.000977	CcSEcCtD
Aprepitant—Vomiting—Dactinomycin—germ cell cancer	0.00023	0.000975	CcSEcCtD
Aprepitant—Rash—Dactinomycin—germ cell cancer	0.000228	0.000967	CcSEcCtD
Aprepitant—Decreased appetite—Etoposide—germ cell cancer	0.000228	0.000965	CcSEcCtD
Aprepitant—Diarrhoea—Ifosfamide—germ cell cancer	0.000227	0.000961	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Etoposide—germ cell cancer	0.000226	0.000958	CcSEcCtD
Aprepitant—Body temperature increased—Cisplatin—germ cell cancer	0.000226	0.000958	CcSEcCtD
Aprepitant—Fatigue—Etoposide—germ cell cancer	0.000226	0.000957	CcSEcCtD
Aprepitant—Constipation—Etoposide—germ cell cancer	0.000224	0.000949	CcSEcCtD
Aprepitant—Pain—Etoposide—germ cell cancer	0.000224	0.000949	CcSEcCtD
Aprepitant—Dizziness—Ifosfamide—germ cell cancer	0.000219	0.000929	CcSEcCtD
Aprepitant—Pharyngitis—Methotrexate—germ cell cancer	0.000219	0.000929	CcSEcCtD
Aprepitant—Urinary tract disorder—Methotrexate—germ cell cancer	0.000218	0.000924	CcSEcCtD
Aprepitant—Urethral disorder—Methotrexate—germ cell cancer	0.000216	0.000917	CcSEcCtD
Aprepitant—Feeling abnormal—Etoposide—germ cell cancer	0.000216	0.000914	CcSEcCtD
Aprepitant—Nausea—Dactinomycin—germ cell cancer	0.000215	0.000911	CcSEcCtD
Aprepitant—Gastrointestinal pain—Etoposide—germ cell cancer	0.000214	0.000907	CcSEcCtD
Aprepitant—Vomiting—Ifosfamide—germ cell cancer	0.000211	0.000893	CcSEcCtD
Aprepitant—Hypersensitivity—Cisplatin—germ cell cancer	0.000211	0.000892	CcSEcCtD
Aprepitant—Rash—Ifosfamide—germ cell cancer	0.000209	0.000886	CcSEcCtD
Aprepitant—Dermatitis—Ifosfamide—germ cell cancer	0.000209	0.000885	CcSEcCtD
Aprepitant—Erythema multiforme—Methotrexate—germ cell cancer	0.000209	0.000885	CcSEcCtD
Aprepitant—Urticaria—Etoposide—germ cell cancer	0.000208	0.000882	CcSEcCtD
Aprepitant—Abdominal pain—Etoposide—germ cell cancer	0.000207	0.000877	CcSEcCtD
Aprepitant—Body temperature increased—Etoposide—germ cell cancer	0.000207	0.000877	CcSEcCtD
Aprepitant—Eye disorder—Methotrexate—germ cell cancer	0.000206	0.000874	CcSEcCtD
Aprepitant—Tinnitus—Methotrexate—germ cell cancer	0.000206	0.000872	CcSEcCtD
Aprepitant—Asthenia—Cisplatin—germ cell cancer	0.000205	0.000869	CcSEcCtD
Aprepitant—Cardiac disorder—Methotrexate—germ cell cancer	0.000205	0.000868	CcSEcCtD
Aprepitant—Angiopathy—Methotrexate—germ cell cancer	0.0002	0.000849	CcSEcCtD
Aprepitant—Immune system disorder—Methotrexate—germ cell cancer	0.000199	0.000845	CcSEcCtD
Aprepitant—Mediastinal disorder—Methotrexate—germ cell cancer	0.000199	0.000843	CcSEcCtD
Aprepitant—Chills—Methotrexate—germ cell cancer	0.000198	0.000839	CcSEcCtD
Aprepitant—Nausea—Ifosfamide—germ cell cancer	0.000197	0.000835	CcSEcCtD
Aprepitant—Diarrhoea—Cisplatin—germ cell cancer	0.000196	0.000829	CcSEcCtD
Aprepitant—Alopecia—Methotrexate—germ cell cancer	0.000195	0.000827	CcSEcCtD
Aprepitant—Mental disorder—Methotrexate—germ cell cancer	0.000193	0.00082	CcSEcCtD
Aprepitant—Hypersensitivity—Etoposide—germ cell cancer	0.000193	0.000818	CcSEcCtD
Aprepitant—Erythema—Methotrexate—germ cell cancer	0.000192	0.000814	CcSEcCtD
Aprepitant—Malnutrition—Methotrexate—germ cell cancer	0.000192	0.000814	CcSEcCtD
Aprepitant—Dysgeusia—Methotrexate—germ cell cancer	0.000188	0.000798	CcSEcCtD
Aprepitant—Asthenia—Etoposide—germ cell cancer	0.000188	0.000796	CcSEcCtD
Aprepitant—Back pain—Methotrexate—germ cell cancer	0.000186	0.000788	CcSEcCtD
Aprepitant—Pruritus—Etoposide—germ cell cancer	0.000185	0.000785	CcSEcCtD
Aprepitant—Vomiting—Cisplatin—germ cell cancer	0.000182	0.00077	CcSEcCtD
Aprepitant—Rash—Cisplatin—germ cell cancer	0.00018	0.000764	CcSEcCtD
Aprepitant—Dermatitis—Cisplatin—germ cell cancer	0.00018	0.000763	CcSEcCtD
Aprepitant—Diarrhoea—Etoposide—germ cell cancer	0.000179	0.000759	CcSEcCtD
Aprepitant—Ill-defined disorder—Methotrexate—germ cell cancer	0.000178	0.000756	CcSEcCtD
Aprepitant—Anaemia—Methotrexate—germ cell cancer	0.000178	0.000753	CcSEcCtD
Aprepitant—Malaise—Methotrexate—germ cell cancer	0.000173	0.000734	CcSEcCtD
Aprepitant—Dizziness—Etoposide—germ cell cancer	0.000173	0.000734	CcSEcCtD
Aprepitant—Nausea—Cisplatin—germ cell cancer	0.00017	0.000719	CcSEcCtD
Aprepitant—Cough—Methotrexate—germ cell cancer	0.000168	0.000711	CcSEcCtD
Aprepitant—Convulsion—Methotrexate—germ cell cancer	0.000167	0.000706	CcSEcCtD
Aprepitant—Vomiting—Etoposide—germ cell cancer	0.000167	0.000706	CcSEcCtD
Aprepitant—Rash—Etoposide—germ cell cancer	0.000165	0.0007	CcSEcCtD
Aprepitant—Dermatitis—Etoposide—germ cell cancer	0.000165	0.000699	CcSEcCtD
Aprepitant—Headache—Etoposide—germ cell cancer	0.000164	0.000695	CcSEcCtD
Aprepitant—Arthralgia—Methotrexate—germ cell cancer	0.000164	0.000693	CcSEcCtD
Aprepitant—Chest pain—Methotrexate—germ cell cancer	0.000164	0.000693	CcSEcCtD
Aprepitant—Myalgia—Methotrexate—germ cell cancer	0.000164	0.000693	CcSEcCtD
Aprepitant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.000163	0.000689	CcSEcCtD
Aprepitant—Discomfort—Methotrexate—germ cell cancer	0.000162	0.000685	CcSEcCtD
Aprepitant—Confusional state—Methotrexate—germ cell cancer	0.000158	0.00067	CcSEcCtD
Aprepitant—Anaphylactic shock—Methotrexate—germ cell cancer	0.000157	0.000665	CcSEcCtD
Aprepitant—Infection—Methotrexate—germ cell cancer	0.000156	0.00066	CcSEcCtD
Aprepitant—Nausea—Etoposide—germ cell cancer	0.000156	0.000659	CcSEcCtD
Aprepitant—Nervous system disorder—Methotrexate—germ cell cancer	0.000154	0.000652	CcSEcCtD
Aprepitant—Thrombocytopenia—Methotrexate—germ cell cancer	0.000154	0.000651	CcSEcCtD
Aprepitant—Skin disorder—Methotrexate—germ cell cancer	0.000152	0.000646	CcSEcCtD
Aprepitant—Hyperhidrosis—Methotrexate—germ cell cancer	0.000152	0.000643	CcSEcCtD
Aprepitant—Anorexia—Methotrexate—germ cell cancer	0.00015	0.000634	CcSEcCtD
Aprepitant—Hypotension—Methotrexate—germ cell cancer	0.000147	0.000621	CcSEcCtD
Aprepitant—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000143	0.000606	CcSEcCtD
Aprepitant—Insomnia—Methotrexate—germ cell cancer	0.000142	0.000601	CcSEcCtD
Aprepitant—Paraesthesia—Methotrexate—germ cell cancer	0.000141	0.000597	CcSEcCtD
Aprepitant—Dyspnoea—Methotrexate—germ cell cancer	0.00014	0.000593	CcSEcCtD
Aprepitant—Somnolence—Methotrexate—germ cell cancer	0.000139	0.000591	CcSEcCtD
Aprepitant—Dyspepsia—Methotrexate—germ cell cancer	0.000138	0.000585	CcSEcCtD
Aprepitant—Decreased appetite—Methotrexate—germ cell cancer	0.000136	0.000578	CcSEcCtD
Aprepitant—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000135	0.000574	CcSEcCtD
Aprepitant—Fatigue—Methotrexate—germ cell cancer	0.000135	0.000573	CcSEcCtD
Aprepitant—Pain—Methotrexate—germ cell cancer	0.000134	0.000568	CcSEcCtD
Aprepitant—Feeling abnormal—Methotrexate—germ cell cancer	0.000129	0.000548	CcSEcCtD
Aprepitant—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000128	0.000544	CcSEcCtD
Aprepitant—Urticaria—Methotrexate—germ cell cancer	0.000125	0.000528	CcSEcCtD
Aprepitant—Body temperature increased—Methotrexate—germ cell cancer	0.000124	0.000525	CcSEcCtD
Aprepitant—Abdominal pain—Methotrexate—germ cell cancer	0.000124	0.000525	CcSEcCtD
Aprepitant—Hypersensitivity—Methotrexate—germ cell cancer	0.000116	0.00049	CcSEcCtD
Aprepitant—Asthenia—Methotrexate—germ cell cancer	0.000113	0.000477	CcSEcCtD
Aprepitant—Pruritus—Methotrexate—germ cell cancer	0.000111	0.00047	CcSEcCtD
Aprepitant—Diarrhoea—Methotrexate—germ cell cancer	0.000107	0.000455	CcSEcCtD
Aprepitant—Dizziness—Methotrexate—germ cell cancer	0.000104	0.00044	CcSEcCtD
Aprepitant—Vomiting—Methotrexate—germ cell cancer	9.97e-05	0.000423	CcSEcCtD
Aprepitant—Rash—Methotrexate—germ cell cancer	9.89e-05	0.000419	CcSEcCtD
Aprepitant—Dermatitis—Methotrexate—germ cell cancer	9.88e-05	0.000419	CcSEcCtD
Aprepitant—Headache—Methotrexate—germ cell cancer	9.83e-05	0.000416	CcSEcCtD
Aprepitant—Nausea—Methotrexate—germ cell cancer	9.32e-05	0.000395	CcSEcCtD
